Filing Details

Accession Number:
0001209191-20-054318
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-08 18:16:03
Reporting Period:
2020-10-06
Accepted Time:
2020-10-08 18:16:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1472012 Immunome Inc. IMNM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405685 Michael Rapp C/O Immunome, Inc.
665 Stockton Drive, Suite 300
Exton PA 19341
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-06 555,554 $0.00 555,554 No 4 C Direct
Common Stock Acquisiton 2020-10-06 83,332 $12.00 638,886 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Convertible Preferred Stock Disposition 2020-10-06 555,554 $0.00 555,554 $0.00
Series A Convertible Preferred Stock Warrant (right to buy) Disposition 2020-10-06 166,666 $0.00 166,666 $9.00
Common Stock Warrant (right to buy) Acquisiton 2020-10-06 166,666 $0.00 166,666 $9.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 2023-06-02 No 4 C Direct
166,666 2023-06-02 No 4 C Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 827,640 Indirect See Footnote
Footnotes
  1. Each share of Series A Convertible Preferred Stock automatically converted into shares of Common Stock upon the closing of theIssuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
  2. The shares are held by BCM Advisory Partners LLC (the "LLC"). The Reporting Person is a managing member of the LLC and has voting and investment power with respect to shares held by the LLC.
  3. Each share of Series A Convertible Preferred Stock underlying this warrant automatically converted into shares of Common Stock upon theclosing of the Issuer's initial public offering for no additional consideration, on a one-for-one basis, and had no expiration date.
  4. Immediately exercisable.